Meeting Report
Biomarker Jeopardy
Presented by Sandra E. Kurtin,(1) PhD, ANP-C, AOCN®, Alyssa Henglefelt,(2) PharmD, BCOP, and Allyson Price,(3) MPAS, PA-C
From (1)The University of Arizona Cancer Center, Tucson, Arizona; (2)HonorHealth Virginia G. Piper Cancer Care Network, Scottsdale, Arizona; (3)The University of Texas MD Anderson Cancer Center, Houston, Texas
J Adv Pract Oncol 2021;12(3):285–288 |
https://doi.org/10.6004/jadpro.2021.12.3.13 |
© 2021 Harborside™
ABSTRACT
The popular Biomarker Jeopardy session returned this year at JADPRO Live 2020. Sandra E. Kurtin, PhD, ANP-C, AOCN®, led the session, and was joined by Alyssa Henglefelt, PharmD, BCOP, and Allyson Price, PA-C. Using a Jeopardy format, they identified specific biomarkers while discussing targeted therapies and class effects APs should be aware of.
For access to the full length article, please
sign in.
